Employees: 470
Size Zhejiang Kaier New Materials (300234.SZ) is a China Industrials company (Miscellaneous Manufacturing) with a market value of $774M, the 2657th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥10.96 on 18 Nov 2026.
Performance Over six months the shares gained 43.3%, against -22.2% for the median peer and -20.0% for the China market (cap-weighted) — highest of 21 in its peer set.
Growth Revenue fell 16.9% over the last twelve months (peer median +5.5%); the operating margin is -9.3% (peer median 7.3%).
Valuation It trades at 17.4× enterprise value to sales against a peer median of 2.5× (most expensive of 21).
Capital Return on invested capital runs 9.5 points below its cost of capital (9.2% WACC).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥277M | CN¥293M | CN¥446M | CN¥612M | CN¥701M |
| Revenue growth | — | -34% | -27% | -13% | — |
| Gross profit | CN¥65.0M | CN¥51.1M | CN¥93.6M | CN¥174M | CN¥166M |
| EBITDA | n/a | CN¥33.1M | CN¥19.4M | CN¥98.7M | CN¥61.9M |
| Net income | -CN¥35.2M | -CN¥9.02M | CN¥23.7M | CN¥74.4M | CN¥73.0M |
| Free cash flow | CN¥19.6M | CN¥99.5M | CN¥136M | CN¥71.6M | -CN¥38.4M |
| Capital expenditure | CN¥3.52M | CN¥9.74M | CN¥18.1M | CN¥31.7M | CN¥49.3M |
| Total debt | CN¥61.0M | CN¥25.4M | CN¥5.98M | CN¥61.5M | CN¥74.4M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 300234.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +1.2% | -9.6% | 2nd highest of 21 |
| 6-month return | +43.3% | -22.2% | highest of 21 |
| Distance from 52-week high | -12.5% | -40.7% | highest of 21 |
| Revenue growth (TTM) | -16.9% | +5.5% | lowest of 21 |
| Operating margin | -9.3% | 7.3% | lowest of 21 |
| EV / Sales | 17.4× | 2.5× | most expensive of 21 |
| ROIC minus cost of capital | -9.5 pp | -2.2 pp | lowest of 21 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | EV / Sales | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Zhejiang Kaier New Materials 300234.SZ | China | $774M | +43% | -17% | -9% | 17.4× | n/a | n/a |
| Unilumin 300232.SZ | China | $772M | -23% | +1% | 0% | 0.7× | 5.9% | +10.3% |
| Shenzhen Jame Technology 300868.SZ | China | $764M | -56% | +8% | -7% | 7.0× | n/a | n/a |
| RHI Magnesita India RHIM.NS | India | $763M | -10% | +4% | 8% | 1.8× | 25.2% | +24.1% |
| Changyuan Technology 600525.SS | China | $760M | -24% | +7% | -7% | 0.9× | -12.9% | +5.1% |
| Zhejiang Goldensea Hi-Tech 603311.SS | China | $791M | -3% | +3% | 7% | 5.6× | n/a | n/a |
| Blue Sail Medical 002382.SZ | China | $801M | -21% | +23% | 7% | 1.2× | -7.2% | -6.1% |
| Apex Dynamics 4583.TW | Taiwan | $813M | -55% | +14% | 33% | 6.6× | 0.7% | +1.1% |
| Hubei Huaqiang High-Tech 688151.SS | China | $718M | -29% | +13% | -5% | 2.9× | 41.6% | -5.6% |
| Jiangsu Changhai Composite Materials 300196.SZ | China | $838M | -31% | +3% | 11% | 1.9× | 2.7% | +9.0% |
| Fuling Technology 001356.SZ | China | $704M | -33% | +17% | 6% | 2.0× | n/a | n/a |
| Genuit GEN.L | United Kingdom | $851M | 0% | +4% | 12% | 1.4× | 12.1% | +8.6% |
| Riverstone AP4.SI | Singapore | $880M | -22% | -4% | 25% | 3.2× | 3.8% | -12.8% |
| Daoming Optics & Chemical 002632.SZ | China | $676M | -33% | -10% | 12% | 3.0× | 5.8% | +3.3% |
| Shanghai Yanpu Precision Technology (Group) 605128.SS | China | $897M | -19% | +3% | 9% | 2.2× | 13.8% | +25.0% |
| Zhejiang Tiantie Science & Technology 300587.SZ | China | $665M | -46% | +24% | -4% | 3.2× | n/a | n/a |
| Jinhua Chunguang Technology 603657.SS | China | $662M | +13% | +22% | -4% | 1.7× | n/a | n/a |
| Cangzhou Mingzhu Plastic 002108.SZ | China | $920M | -33% | +14% | 5% | 2.7× | n/a | n/a |
| Jiangsu Boiln Plastics 301003.SZ | China | $646M | -19% | +7% | 20% | 6.0× | 19.9% | +3.6% |
| Sichuan Goldstone Asia Pharmaceutical 300434.SZ | China | $639M | -6% | -1% | 18% | 3.6× | 9.2% | +6.2% |
| Finolex Industries FINPIPE.NS | India | $958M | -13% | +3% | 14% | 1.6× | 13.5% | +3.5% |